https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
This publication reports on newly diagnosed cancers registered in England during 2022. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document. Cancer registration estimates are provided for: • Incidence of cancer using groupings that incorporate both the location and type of cancer by combinations of gender, age, deprivation, and stage at diagnosis (where appropriate) for England, former Government office regions, Cancer alliances and Integrated care boards • Incidence and mortality (using ICD-10 3-digit codes) by gender and age group for England, former Government office regions, Cancer alliances and Integrated care boards This publication will report on 2022 cancer registrations only, trends will not be reported as the required re-stated populations for 2012 to 2020 are not expected to be published by the Office of National Statistics (ONS) until Winter 2024.
This release summarises the diagnoses in 2019 registered by NDRS covering all registerable neoplasms (all cancers, all in situ tumours, some benign tumours and all tumours that have uncertain or unknown behaviours)
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Cancer diagnoses and age-standardised incidence rates for all types of cancer by age and sex including breast, prostate, lung and colorectal cancer.
This statistic shows the rate of registrations of newly diagnosed cases of lung cancer per 100,000 population in England in 2020, by region and gender. With a rate of 100.8 newly diagnosed males with lung cancer and 90.8 females per 100,000 population in 2020, the region most affected by lung cancer was the North East.
This statistic shows the amount of registrations of newly diagnosed cases of lung cancer in England in 2021, by age group and gender. In this year, almost four thousand cases were reported among men aged 70 to 74 years. It should be noted that the number of people in England in each age group varies and is therefore not necessarily a reflection of susceptibility to lung cancer.
In 2021, approximately 666 males per 100,000 and 557 females per 100,000 in England were newly diagnosed with cancer, excluding non-melanoma skin cancer. Overall, the diagnosis rate for males showed a slight decreasing trend over the years, while the rate for females remained relatively stable with minor changes. This statistic shows the rate of newly diagnosed cases of cancer per 100,000 population in England from 2018 to 2021, by gender.
In 2021, 172.9 females per 100,000 population were registered in England as newly diagnosed with breast cancer. This was an overall increase in comparison to the last few years' rate of registration, and a steep rise from the drop in the rate of registration reported in 2020. This statistic shows the rate of newly diagnosed female cases of breast cancer per 100,000 population in England from 1995 to 2021.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
One-year and five-year net survival for adults (15-99) in England diagnosed with one of 29 common cancers, by age and sex.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Cancer Prevalence Statistics from the National Disease Registration Service publishes data on the number of people living with and beyond a cancer diagnosis on a given date (index date). The index date for the present publication is 31 December 2021. Understanding the size of the population living with and beyond a cancer diagnosis at a point in time can support planning for the delivery of local health and social care services, quantify the ‘burden’ of disease in an area or population and could determine the number of people who may have unmet health needs that could potentially benefit from new treatment interventions. The publication includes an interactive dashboard and data workbook for download. Detailed methodology notes are included at the Cancer Prevalence Statistics home page. The data are anonymous and available in an open format for anyone to access and use. Cancer prevalence Statistics are provided for all cancers combined as well as 24 cancer sites for England and sub-national geographies as follows: Cancer Alliance; Integrated Care Board; Local Authority. If you have feedback or any other queries about Cancer Prevalence, please email us at NDRSenquires@nhs.net and mention 'Cancer Prevalence Statistics' in your email.
This statistic shows the rate of registrations of newly diagnosed cases of pancreatic cancer per 100,000 population in England in 2020, by region and gender. In this year, the rate of newly diagnosed cases of pancreatic cancer among women was highest in South East region of England at 16.1 cases per 100,000 population, whereas the highest rate among men was in North East region at 21 per 100,000 population.
In 2021, 81.5 males and 66.1 females per 100,000 population in England were registered as newly diagnosed with malignant neoplasm of trachea, bronchus and lung. Over the analyzed years, the rate of newly diagnosed cases for male individuals has seen a decrease trend. Conversely, the rate of newly diagnosed cases for females has seen a steady increase over the years. This statistic shows the rate of newly diagnosed cases of lung cancer per 100,000 population in England from 1995 to 2021, by gender.
Time to diagnosis in secondary care is described by cancer site and route to diagnosis (emergency presentation, GP referral and Two Week Wait – urgent referral for suspected cancer). This release contains interval data for cancers diagnosed in 2014 and 2015 in 24 different cancer sites.
This commentary accompanies an interactive tool that presents these diagnostic intervals and frequencies by age at diagnosis, stage at diagnosis, broad ethnic group, Charlson comorbidity index, income deprivation, sex and Cancer Alliance.
This publication sets out and comments on stage at cancer diagnosis in Clinical Commissioning Groups in England for patients diagnosed in the period 2013 to 2018. Proportion of cancers diagnosed at an early stage are presented unadjusted and adjusted for case-mix (age, sex, cancer site and socio-economic deprivation). Supporting data quality and stage completeness are presented for persons diagnosed 2001 to 2018.
The 21 cancer groups are defined as those with 1,500 cancers diagnosed annually in England and 70% staging completeness.
The statistics are obtained from the National Cancer Registration Dataset that is collected, quality assured and analysed by the National Cancer Registration and Analysis Service, part of Public Health England.
Official statistics are produced impartially and free from political influence.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Legacy unique identifier: P00509
This statistic shows the number of deaths from cervical cancer in England from 2014 to 2021. In 2021, the number of deaths from cervical cancer reached 702, an increase from 681 deaths in 2020.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Legacy unique identifier: P00630
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Cancer registrations for Breast cancer per 100,000 population. Directly standardised registration rate Source: Regional Cancer Registries, Office for National Statistics (ONS). Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2004-2006 Type of data: Administrative data
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Information on the waiting times of patients with suspected cancer and those subsequently diagnosed with cancer
Source agency: NHS England
Designation: National Statistics
Language: English
Alternative title: Statistics on Waiting Times for Suspected and Diagnosed Cancer Patients Annual Report
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Deaths from stomach cancer - Directly age-Standardised Rates (DSR) per 100,000 population Source: Office for National Statistics (ONS) Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Primary Care Trust (PCT), Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2005-07, 2007 Type of data: Administrative data
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
This publication reports on newly diagnosed cancers registered in England during 2022. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document. Cancer registration estimates are provided for: • Incidence of cancer using groupings that incorporate both the location and type of cancer by combinations of gender, age, deprivation, and stage at diagnosis (where appropriate) for England, former Government office regions, Cancer alliances and Integrated care boards • Incidence and mortality (using ICD-10 3-digit codes) by gender and age group for England, former Government office regions, Cancer alliances and Integrated care boards This publication will report on 2022 cancer registrations only, trends will not be reported as the required re-stated populations for 2012 to 2020 are not expected to be published by the Office of National Statistics (ONS) until Winter 2024.